首页 > 最新文献

Diseases of the Esophagus最新文献

英文 中文
428. PHARYNGEAL SQUAMOUS CELL CARCINOMA AND RISK OF LATER ESOPHAGEAL SQUAMOUS CELL CARCINOMA 咽鳞状细胞癌与晚期食管鳞状细胞癌的风险
IF 2.6 3区 医学 Q3 GASTROENTEROLOGY & HEPATOLOGY Pub Date : 2023-08-30 DOI: 10.1093/dote/doad052.221
P. Elbe, Isabella Ekheden, M. Vujasinovic, J. Maret-Ouda, E. Marsk, M. Thuresson, B. Roelstraete, W. Ye, J. Ludvigsson
Pharyngeal squamous cell carcinoma is a known risk factor for later squamous cell carcinoma of the esophagus. We investigated whether the risk of esophageal carcinoma is high enough to justify routine gastroscopy surveillance in a northern European population. If the risk among patients with pharyngeal carcinoma corresponds to the risk among patients with Barretts esophagus of developing adenocarcinoma, it could justify surveillance. Histopathology data from pharyngeal and esophageal biopsies obtained 1980–2016 in Sweden’s 28 pathology departments were linked to national population-based healthcare registers. We calculated a subdistribution hazard ratio (HR) comparing the risk of esophageal cancer and death in patients with pharyngeal carcinoma to a matched general population. In total 1399 patients with pharyngeal cancer were identified. 344 were excluded due to age under 18 years, previous esophageal cancer, death or cancer within 6 months of diagnosis. Thus, 1055 patients remained. Median follow up time was 5,1 years. 78% were men and median age at diagnosis of pharyngeal cancer was 64 years. Four (0.38%) patients developed esophageal squamous cell carcinoma during follow-up, equal to 1 in 263 patients (HR = 14,32; 95%CI = 1,55-132,30). 855 of the patients (81%) died during follow-up (HR = 7,65; 95% = 6,82-8,59). The yearly risk of developing esophageal squamous cell carcinoma was 0,07%, which is lower than the risk among patients with Barretts esophagus. Therefore, we find no support for long-term endoscopic surveillance among patients with pharyngeal cancer.
咽部鳞状细胞癌是后来发生食管鳞状细胞癌的已知危险因素。我们调查了食管癌的风险是否高到足以证明在北欧人群中进行常规胃镜检查的合理性。如果咽癌患者发生腺癌的风险与巴雷特食管患者发生腺癌的风险相对应,则有必要进行监测。1980-2016年在瑞典28个病理部门获得的咽和食管活检的组织病理学数据与全国基于人口的医疗保健登记册相关联。我们计算了一个亚分布风险比(HR),比较了咽癌患者与匹配的一般人群中食管癌和死亡的风险。共有1399例咽癌患者被确诊。344人因年龄在18岁以下、既往食管癌、死亡或诊断后6个月内患癌症而被排除在外。因此,保留了1055例患者。中位随访时间为5.1年。78%为男性,诊断咽喉癌时的中位年龄为64岁。4例(0.38%)患者在随访期间发生食管鳞状细胞癌,相当于263例患者中有1例(HR = 14,32;95%ci = 1,55-132,30)。855例(81%)患者在随访期间死亡(HR = 7,65;95% = 6,82-8,59)。每年发生食管鳞状细胞癌的风险为0.07%,低于巴雷特食管患者的风险。因此,我们发现在咽癌患者中不支持长期内镜监测。
{"title":"428. PHARYNGEAL SQUAMOUS CELL CARCINOMA AND RISK OF LATER ESOPHAGEAL SQUAMOUS CELL CARCINOMA","authors":"P. Elbe, Isabella Ekheden, M. Vujasinovic, J. Maret-Ouda, E. Marsk, M. Thuresson, B. Roelstraete, W. Ye, J. Ludvigsson","doi":"10.1093/dote/doad052.221","DOIUrl":"https://doi.org/10.1093/dote/doad052.221","url":null,"abstract":"Pharyngeal squamous cell carcinoma is a known risk factor for later squamous cell carcinoma of the esophagus. We investigated whether the risk of esophageal carcinoma is high enough to justify routine gastroscopy surveillance in a northern European population. If the risk among patients with pharyngeal carcinoma corresponds to the risk among patients with Barretts esophagus of developing adenocarcinoma, it could justify surveillance.\u0000 \u0000 \u0000 \u0000 Histopathology data from pharyngeal and esophageal biopsies obtained 1980–2016 in Sweden’s 28 pathology departments were linked to national population-based healthcare registers. We calculated a subdistribution hazard ratio (HR) comparing the risk of esophageal cancer and death in patients with pharyngeal carcinoma to a matched general population.\u0000 \u0000 \u0000 \u0000 In total 1399 patients with pharyngeal cancer were identified. 344 were excluded due to age under 18 years, previous esophageal cancer, death or cancer within 6 months of diagnosis. Thus, 1055 patients remained. Median follow up time was 5,1 years. 78% were men and median age at diagnosis of pharyngeal cancer was 64 years. Four (0.38%) patients developed esophageal squamous cell carcinoma during follow-up, equal to 1 in 263 patients (HR = 14,32; 95%CI = 1,55-132,30). 855 of the patients (81%) died during follow-up (HR = 7,65; 95% = 6,82-8,59).\u0000 \u0000 \u0000 \u0000 The yearly risk of developing esophageal squamous cell carcinoma was 0,07%, which is lower than the risk among patients with Barretts esophagus. Therefore, we find no support for long-term endoscopic surveillance among patients with pharyngeal cancer.","PeriodicalId":11354,"journal":{"name":"Diseases of the Esophagus","volume":" ","pages":""},"PeriodicalIF":2.6,"publicationDate":"2023-08-30","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"42717454","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":3,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
393. A RADIOMICS STRATEGY BASED ON CT INTRA-TUMORAL AND PERITUMORAL REGIONS FOR PREOPERATIVE PREDICTION OF NEOADJUVANT CHEMORADIOTHERAPY FOR ESOPHAGEAL CANCER 393.一种基于CT肿瘤内和肿瘤周围区域的放射组学策略,用于食管癌新辅助放化疗的术前预测
IF 2.6 3区 医学 Q3 GASTROENTEROLOGY & HEPATOLOGY Pub Date : 2023-08-30 DOI: 10.1093/dote/doad052.195
Yun Wang, Zhiyang Li
The standard treatment for esophageal cancer patients is neoadjuvant chemoradiotherapy followed by surgery. However, some of these patients do not achieve pathological complete response with this therapy, resulting in poor outcomes. The objective of this study is to develop a method for selecting patients who can achieve pathological complete response through pre-neoadjuvant therapy chest-enhanced CT scans. The study enrolled 201 patients with esophageal cancer and divided them into a training set and a testing set in a 7:3 ratio. Radiomics features of intra-tumoral and peritumoral images were extracted from preoperative chest-enhanced CT scans of these patients. The features underwent dimensionality reduction in two steps, using Student’s t-test and least absolute shrinkage and selection operator. The selected intra-tumoral and peritumoral (including marginal and adjacent ROI) features were used to build models with four machine learning classifiers. The models with satisfactory accuracy and stability levels were considered to perform well. Finally, the performance of these well-performing models on the testing set was displayed using ROC curves. Among the 16 models, the best-performing models were the integrated (intra-tumoral and peritumoral features) -XGBoost and integrated-random forest models. In the training set, the two models had average ROC AUCs of 0.906 and 0.918 respectively, with relative standard deviations (RSDs) of 6.26 and 6.89. In the testing set, the AUCs were 0.845 and 0.871, respectively. There was no significant difference in the ROC curves between the two models. The addition of peritumoral radiomics features to the radiomics analysis may improve the predictive performance of pathological response for esophageal cancer patients to neoadjuvant chemoradiotherapy. The integrated (intra-tumoral and peritumoral features) -XGBoost and integrated-random forest models developed in this study show potential for predicting pathological complete response in esophageal cancer patients and may help in selecting patients for neoadjuvant therapy.
食管癌症患者的标准治疗方法是新辅助放化疗,然后进行手术。然而,这些患者中的一些人没有通过这种治疗获得病理学上的完全反应,导致不良结果。本研究的目的是开发一种方法,选择能够通过新辅助治疗前胸部增强CT扫描获得病理完全反应的患者。该研究招募了201名癌症食管癌患者,并将他们按7:3的比例分为训练组和测试组。从这些患者术前胸部增强CT扫描中提取肿瘤内和肿瘤周围图像的放射组学特征。使用Student t检验和最小绝对收缩和选择算子,分两步对特征进行降维。所选择的肿瘤内和肿瘤周围(包括边缘和邻近ROI)特征用于构建具有四个机器学习分类器的模型。具有令人满意的精度和稳定性水平的模型被认为表现良好。最后,使用ROC曲线显示了这些性能良好的模型在测试集上的性能。在16个模型中,表现最好的模型是综合(肿瘤内和肿瘤周围特征)-XGBost和综合随机森林模型。在训练集中,两个模型的平均ROC AUC分别为0.906和0.918,相对标准偏差(RSD)分别为6.26和6.89。在测试集中,AUC分别为0.845和0.871。两个模型之间的ROC曲线没有显著差异。在放射组学分析中添加肿瘤周围放射组学特征可以提高癌症患者对新辅助放化疗的病理反应的预测性能。本研究中开发的整合(肿瘤内和肿瘤周围特征)-XGBoost和整合随机森林模型显示了预测食管癌症患者病理完全反应的潜力,并可能有助于选择新辅助治疗的患者。
{"title":"393. A RADIOMICS STRATEGY BASED ON CT INTRA-TUMORAL AND PERITUMORAL REGIONS FOR PREOPERATIVE PREDICTION OF NEOADJUVANT CHEMORADIOTHERAPY FOR ESOPHAGEAL CANCER","authors":"Yun Wang, Zhiyang Li","doi":"10.1093/dote/doad052.195","DOIUrl":"https://doi.org/10.1093/dote/doad052.195","url":null,"abstract":"\u0000 \u0000 \u0000 The standard treatment for esophageal cancer patients is neoadjuvant chemoradiotherapy followed by surgery. However, some of these patients do not achieve pathological complete response with this therapy, resulting in poor outcomes. The objective of this study is to develop a method for selecting patients who can achieve pathological complete response through pre-neoadjuvant therapy chest-enhanced CT scans.\u0000 \u0000 \u0000 \u0000 The study enrolled 201 patients with esophageal cancer and divided them into a training set and a testing set in a 7:3 ratio. Radiomics features of intra-tumoral and peritumoral images were extracted from preoperative chest-enhanced CT scans of these patients. The features underwent dimensionality reduction in two steps, using Student’s t-test and least absolute shrinkage and selection operator. The selected intra-tumoral and peritumoral (including marginal and adjacent ROI) features were used to build models with four machine learning classifiers. The models with satisfactory accuracy and stability levels were considered to perform well. Finally, the performance of these well-performing models on the testing set was displayed using ROC curves.\u0000 \u0000 \u0000 \u0000 Among the 16 models, the best-performing models were the integrated (intra-tumoral and peritumoral features) -XGBoost and integrated-random forest models. In the training set, the two models had average ROC AUCs of 0.906 and 0.918 respectively, with relative standard deviations (RSDs) of 6.26 and 6.89. In the testing set, the AUCs were 0.845 and 0.871, respectively. There was no significant difference in the ROC curves between the two models.\u0000 \u0000 \u0000 \u0000 The addition of peritumoral radiomics features to the radiomics analysis may improve the predictive performance of pathological response for esophageal cancer patients to neoadjuvant chemoradiotherapy. The integrated (intra-tumoral and peritumoral features) -XGBoost and integrated-random forest models developed in this study show potential for predicting pathological complete response in esophageal cancer patients and may help in selecting patients for neoadjuvant therapy.\u0000","PeriodicalId":11354,"journal":{"name":"Diseases of the Esophagus","volume":" ","pages":""},"PeriodicalIF":2.6,"publicationDate":"2023-08-30","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"49585981","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":3,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
433. INTRAOPERATIVE ICG-IMAGING AS A TOOL TO ASSESS PERFUSION IN THE GASTRIC CONDUIT 433.术中ICG成像作为评估胃导管灌注的工具
IF 2.6 3区 医学 Q3 GASTROENTEROLOGY & HEPATOLOGY Pub Date : 2023-08-30 DOI: 10.1093/dote/doad052.225
Karoliina Niska
In curative surgery for esophageal cancer a gastric conduit is often used to replace the resected esophagus. Anastomotic leakage (AL) is a serious complication. Sufficient perfusion in the gastric conduit is critical for the anastomosis. The aim of this pilot study was to investigate the feasibility of intraoperative indocyanine green (ICG) and near-infrared fluorescent imaging as a tool to assess perfusion of the gastric conduit in order to prevent postoperative AL. Patients undergoing esophageal resection at Umeå University Hospital were invited to participate in this prospective study during 2017–2022. The surgery performed was open Ivor-Lewis esophagectomy. ICG was administered intraoperatively and video footage of the near-infrared fluorescence was recorded. The time from injection until visualized fluorescence in the gastric conduit was measured, as well as the intensity of the fluorescence in the gastric conduit. A loop of jejunum was used as control and the quotient between the measurement in the jejunal loop and in the gastric conduit was used for objective assessment. 50 individuals were included. 46 patients had received neoadjuvant chemoradiotherapy and 3 had received chemotherapy only. 32 patients had video footages that were possible to assess as described above. Of these 11 had AL. No differences were demonstrated between patients with AL and those without, neither regarding time to fluorescence (p = 0.42), nor intensity (p = 0.72). AL is a serious complication to esophageal surgery with a high incidence. Perfusion assessment of the gastric conduit using ICG has emerged as a promising technique to reduce AL. In this pilot study we developed two techniques to evaluate the perfusion in an objective manner, whilst none of these seem to be able to predict postoperative AL.
在食管癌症的治疗手术中,通常使用胃导管代替切除的食管。吻合口瘘是一种严重的并发症。胃导管中的充足灌注对于吻合至关重要。这项试点研究的目的是调查术中吲哚菁绿(ICG)和近红外荧光成像作为评估胃导管灌注以预防术后AL的工具的可行性。2017年至2022年,乌莫大学医院接受食管切除术的患者被邀请参与这项前瞻性研究。手术采用开放式Ivor-Lewis食管切除术。术中给予ICG,并记录近红外荧光的视频片段。测量从注射到胃导管中出现荧光的时间,以及胃导管中荧光的强度。使用空肠环作为对照,并使用空肠环和胃导管中的测量值之间的商进行客观评估。包括50个人。46例患者接受了新辅助放化疗,3例仅接受了化疗。32名患者的视频足迹可以如上所述进行评估。其中11例有AL。AL患者和无AL患者之间没有差异,荧光时间也没有差异(p = 0.42),也没有强度(p = 0.72)。AL是食管手术的严重并发症,发病率高。使用ICG对胃导管进行灌注评估已成为一种很有前途的减少AL的技术。在这项初步研究中,我们开发了两种技术来客观评估灌注,但这些技术似乎都无法预测术后AL。
{"title":"433. INTRAOPERATIVE ICG-IMAGING AS A TOOL TO ASSESS PERFUSION IN THE GASTRIC CONDUIT","authors":"Karoliina Niska","doi":"10.1093/dote/doad052.225","DOIUrl":"https://doi.org/10.1093/dote/doad052.225","url":null,"abstract":"\u0000 \u0000 \u0000 In curative surgery for esophageal cancer a gastric conduit is often used to replace the resected esophagus. Anastomotic leakage (AL) is a serious complication. Sufficient perfusion in the gastric conduit is critical for the anastomosis. The aim of this pilot study was to investigate the feasibility of intraoperative indocyanine green (ICG) and near-infrared fluorescent imaging as a tool to assess perfusion of the gastric conduit in order to prevent postoperative AL.\u0000 \u0000 \u0000 \u0000 Patients undergoing esophageal resection at Umeå University Hospital were invited to participate in this prospective study during 2017–2022. The surgery performed was open Ivor-Lewis esophagectomy. ICG was administered intraoperatively and video footage of the near-infrared fluorescence was recorded. The time from injection until visualized fluorescence in the gastric conduit was measured, as well as the intensity of the fluorescence in the gastric conduit. A loop of jejunum was used as control and the quotient between the measurement in the jejunal loop and in the gastric conduit was used for objective assessment.\u0000 \u0000 \u0000 \u0000 50 individuals were included. 46 patients had received neoadjuvant chemoradiotherapy and 3 had received chemotherapy only. 32 patients had video footages that were possible to assess as described above. Of these 11 had AL. No differences were demonstrated between patients with AL and those without, neither regarding time to fluorescence (p = 0.42), nor intensity (p = 0.72).\u0000 \u0000 \u0000 \u0000 AL is a serious complication to esophageal surgery with a high incidence. Perfusion assessment of the gastric conduit using ICG has emerged as a promising technique to reduce AL. In this pilot study we developed two techniques to evaluate the perfusion in an objective manner, whilst none of these seem to be able to predict postoperative AL.\u0000 \u0000","PeriodicalId":11354,"journal":{"name":"Diseases of the Esophagus","volume":" ","pages":""},"PeriodicalIF":2.6,"publicationDate":"2023-08-30","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"46096285","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":3,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
342. VIDEO-ASSISTED THORACOSCOPIC ENUCLEATION OF BENIGN SCHWANNOMA MISDIAGNOSED AS MALIGNANT LESION ON F-18 FDG PET/CT IN ESOPHAGEAL SUBMUCOSAL TUMOR 食管黏膜下肿瘤F-18fdgpet/CT诊断为恶性病变的良性神经鞘瘤电视胸腔镜摘除术
IF 2.6 3区 医学 Q3 GASTROENTEROLOGY & HEPATOLOGY Pub Date : 2023-08-30 DOI: 10.1093/dote/doad052.156
Sung Kwang Lee
Esophageal SMT is a rare disease, and most of them are benign. Esophageal schwannoma accounts for about 2% among esophageal SMT. Recently, F-18 FDG PET/CT has been widely used to confirm malignancy or to identify other metastatic lesions in cancer patients. However, even benign tumors often show an elevated SUV, and in the case of schwannomas, various values of SUV have been reported, which seems to limit differentiation from other malignant peripheral nerve sheath tumors. A 56-year-old female patient was incidentally found with extrinsic compressing mass at 22 cm from the incisor. An endoscopic ultrasonography and chest CT showed a 3.4 cm sized homogenous well-defined mass in upper esophagus, leiomyoma or gastrointestinal stromal tumor was suspected. SUV was elevated on PET-CT was performed to identify malignancy and metastatic lesions. When confirmed as malignant, additional surgery was planned, and enucleation was performed for primary diagnosis and treatment. The esophageal bulging was confirmed. After dividing the esophageal muscle, and underwent enucleation. In immunohistochemical staining, S-100 protein showed positive findings, which could be diagnosed as schwannoma. Due to the characteristics of esophageal SMT, FDG uptake may be observed on PET-CT, but if there is no evidence of metastasis, it is likely to proceed with treatment according to the benign disease. Then, if immunohistochemistry examination is diagnosed as malignancy, it would be desirable to apply additional stage surgery.
食管SMT是一种罕见的疾病,大多数是良性的。食管神经鞘瘤在食管SMT中约占2%。最近,F-18FDGPET/CT已被广泛用于癌症患者的恶性肿瘤或其他转移病灶的确认。然而,即使是良性肿瘤也经常表现出SUV升高,在神经鞘瘤的情况下,SUV的各种值已经被报道,这似乎限制了与其他恶性周围神经鞘肿瘤的鉴别。一位56岁的女性患者偶然发现在离切牙22厘米处有外源性压迫性肿块。内窥镜超声和胸部CT显示,食道上部有一个3.4厘米大小的均匀明确的肿块,怀疑是平滑肌瘤或胃肠道间质瘤。SUV在PET-CT上升高,以确定恶性肿瘤和转移性病变。当被确认为恶性时,计划进行额外的手术,并进行摘除以进行初步诊断和治疗。食道膨出已被证实。食管肌切开后,行摘除术。免疫组化染色显示S-100蛋白阳性,可诊断为神经鞘瘤。由于食管SMT的特点,PET-CT上可能观察到FDG的摄取,但如果没有转移的证据,则可能根据良性疾病进行治疗。然后,如果免疫组织化学检查被诊断为恶性肿瘤,则需要进行额外阶段的手术。
{"title":"342. VIDEO-ASSISTED THORACOSCOPIC ENUCLEATION OF BENIGN SCHWANNOMA MISDIAGNOSED AS MALIGNANT LESION ON F-18 FDG PET/CT IN ESOPHAGEAL SUBMUCOSAL TUMOR","authors":"Sung Kwang Lee","doi":"10.1093/dote/doad052.156","DOIUrl":"https://doi.org/10.1093/dote/doad052.156","url":null,"abstract":"\u0000 \u0000 \u0000 Esophageal SMT is a rare disease, and most of them are benign. Esophageal schwannoma accounts for about 2% among esophageal SMT.\u0000 Recently, F-18 FDG PET/CT has been widely used to confirm malignancy or to identify other metastatic lesions in cancer patients. However, even benign tumors often show an elevated SUV, and in the case of schwannomas, various values of SUV have been reported, which seems to limit differentiation from other malignant peripheral nerve sheath tumors.\u0000 \u0000 \u0000 \u0000 A 56-year-old female patient was incidentally found with extrinsic compressing mass at 22 cm from the incisor. An endoscopic ultrasonography and chest CT showed a 3.4 cm sized homogenous well-defined mass in upper esophagus, leiomyoma or gastrointestinal stromal tumor was suspected. SUV was elevated on PET-CT was performed to identify malignancy and metastatic lesions. When confirmed as malignant, additional surgery was planned, and enucleation was performed for primary diagnosis and treatment.\u0000 The esophageal bulging was confirmed. After dividing the esophageal muscle, and underwent enucleation. In immunohistochemical staining, S-100 protein showed positive findings, which could be diagnosed as schwannoma.\u0000 \u0000 \u0000 \u0000 Due to the characteristics of esophageal SMT, FDG uptake may be observed on PET-CT, but if there is no evidence of metastasis, it is likely to proceed with treatment according to the benign disease. Then, if immunohistochemistry examination is diagnosed as malignancy, it would be desirable to apply additional stage surgery.\u0000 \u0000","PeriodicalId":11354,"journal":{"name":"Diseases of the Esophagus","volume":" ","pages":""},"PeriodicalIF":2.6,"publicationDate":"2023-08-30","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"41793521","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":3,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
307. A REVIEW OF 31 SUPERFICIAL ESOPHAGEAL CANCER CASES WITHOUT HISTORY OF HABITUAL DRINKING OR SMOKING OBSERVED IN OUR HOSPITAL 307.我院31例无习惯性饮酒或吸烟史的浅表性食管癌病例回顾性分析
IF 2.6 3区 医学 Q3 GASTROENTEROLOGY & HEPATOLOGY Pub Date : 2023-08-30 DOI: 10.1093/dote/doad052.130
A. Ishiyama, Chika Fukuyama, Hiroyuki Yamamoto, Y. Ikenoyama, K. Namikawa, Y. Tokai, T. Yoshio, J. Fujisaki
In Japan, alcohol consumption, smoking, and genetic an aldehyde dehydrogenase 2 polymorphisms are risk factors for most esophageal squamous cell carcinomas(ESCC). However, only a limited number of cases have been observed without these risk factors in daily practice. This study aimed to evaluate the endoscopic findings of 31 lesions in 29 patients with ESCC who underwent endoscopic submucosal dissection (ESD) at our hospital without a history of habitual alcohol consumption or smoking (hereafter referred to as ‘risk factors’). Patients and Methods: We retrospectively examined the endoscopic findings, final diagnoses, and patient and lesion backgrounds of 31 lesions from 29 patients of ESCC without risk factors who underwent ESD from January 2017 to December 2022 at our hospital. A total of 27 women and two men, median age 72 (44–87) years, were included; 10 patients were on proton pump inhibitors, 12 patients had a history of cancer, and 12 patients had a family history of cancer in the first degree. Additionally, three patients had multiple heterochronic lesions, one patient had a speckled esophagus, and two patients had grade B gastroesophageal reflux disease according to the revised Los Angeles classification. Occupied site; Ut/Mt/Lt = 4/24/3, circumferential; anterior/posterior/left/right wall = 0/16/10/5, macroscopic type; 0-IIa/0-IIb/0-IIc/mixed type = 4/10/15/2, median lesion length 17(5–45) mm, wall depth; EP/LPM/MM/SM1 = 11/18/1/1/1, all vascular invasions were negative. A total of 22 lesions had white-tone mucosa on their surface, suggesting superficial keratinization or hyperkeratinization. The lesions were diverse in shape. Additionally, seven lesions were observed which tended to run longitudinally with long axial lengths, all located on the posterior wall of Mt, and white adherent material was observed in six lesions. Iodine staining was performed in 30 lesions, all of which were unstained, and six of them had indistinct borders with inflammatory changes in the background. A total of three patients had synchronous/heterochronic multiple esophageal cancers. The white adherents running longitudinally in the posterior wall of the Mt and its white tone in patients with no risk factors suggest the possibility of previously unrecognized lesions and the need for close endoscopic examination, along with iodine staining and biopsy.
在日本,饮酒、吸烟和遗传性乙醛脱氢酶2多态性是大多数食管鳞状细胞癌(ESCC)的危险因素。然而,在日常实践中,只有少数病例没有这些风险因素。本研究旨在评估29名ESCC患者的31个病变的内镜检查结果,这些患者在我院接受了内镜下黏膜下剥离术(ESD),没有习惯性饮酒或吸烟史(以下简称“风险因素”)。患者和方法:我们回顾性检查了2017年1月至2022年12月在我院接受ESD治疗的29名无危险因素ESCC患者的31个病变的内镜检查结果、最终诊断以及患者和病变背景。共有27名女性和两名男性,中位年龄72岁(44-87岁);10例患者服用质子泵抑制剂,12例患者有癌症病史,12例有一级癌症家族史。此外,根据修订后的洛杉矶分类,三名患者有多个异时病变,一名患者有斑点食道,两名患者有B级胃食管反流病。占用场地;Ut/Mt/Lt = 4/24/3,周向;前/后/左/右壁 = 0/16/10/5,宏观型;0-IIa/0-IIb/0-IIc/混合型 = 4/10/15/2,中位病变长度17(5-45)mm,壁深;EP/LPM/MM/SM1 = 11/18/1/1/1,所有血管侵犯均为阴性。共有22个病变表面有白色粘膜,提示浅表角化或过度角化。病变形态多样。此外,观察到7个病变,这些病变倾向于纵向延伸,轴向长度较长,均位于Mt的后壁上,在6个病变中观察到白色粘附物质。对30个病灶进行了碘染色,所有病灶均未染色,其中6个病灶边界模糊,背景有炎症变化。共有三名患者患有同步/异时性多发性食管癌。在没有危险因素的患者中,Mt后壁纵向排列的白色粘附物及其白色色调表明可能存在以前未识别的病变,需要进行密切的内镜检查以及碘染色和活检。
{"title":"307. A REVIEW OF 31 SUPERFICIAL ESOPHAGEAL CANCER CASES WITHOUT HISTORY OF HABITUAL DRINKING OR SMOKING OBSERVED IN OUR HOSPITAL","authors":"A. Ishiyama, Chika Fukuyama, Hiroyuki Yamamoto, Y. Ikenoyama, K. Namikawa, Y. Tokai, T. Yoshio, J. Fujisaki","doi":"10.1093/dote/doad052.130","DOIUrl":"https://doi.org/10.1093/dote/doad052.130","url":null,"abstract":"\u0000 \u0000 \u0000 In Japan, alcohol consumption, smoking, and genetic an aldehyde dehydrogenase 2 polymorphisms are risk factors for most esophageal squamous cell carcinomas(ESCC). However, only a limited number of cases have been observed without these risk factors in daily practice.\u0000 \u0000 \u0000 \u0000 This study aimed to evaluate the endoscopic findings of 31 lesions in 29 patients with ESCC who underwent endoscopic submucosal dissection (ESD) at our hospital without a history of habitual alcohol consumption or smoking (hereafter referred to as ‘risk factors’).\u0000 Patients and Methods: We retrospectively examined the endoscopic findings, final diagnoses, and patient and lesion backgrounds of 31 lesions from 29 patients of ESCC without risk factors who underwent ESD from January 2017 to December 2022 at our hospital.\u0000 \u0000 \u0000 \u0000 A total of 27 women and two men, median age 72 (44–87) years, were included; 10 patients were on proton pump inhibitors, 12 patients had a history of cancer, and 12 patients had a family history of cancer in the first degree. Additionally, three patients had multiple heterochronic lesions, one patient had a speckled esophagus, and two patients had grade B gastroesophageal reflux disease according to the revised Los Angeles classification. Occupied site; Ut/Mt/Lt = 4/24/3, circumferential; anterior/posterior/left/right wall = 0/16/10/5, macroscopic type; 0-IIa/0-IIb/0-IIc/mixed type = 4/10/15/2, median lesion length 17(5–45) mm, wall depth; EP/LPM/MM/SM1 = 11/18/1/1/1, all vascular invasions were negative. A total of 22 lesions had white-tone mucosa on their surface, suggesting superficial keratinization or hyperkeratinization. The lesions were diverse in shape. Additionally, seven lesions were observed which tended to run longitudinally with long axial lengths, all located on the posterior wall of Mt, and white adherent material was observed in six lesions. Iodine staining was performed in 30 lesions, all of which were unstained, and six of them had indistinct borders with inflammatory changes in the background. A total of three patients had synchronous/heterochronic multiple esophageal cancers.\u0000 \u0000 \u0000 \u0000 The white adherents running longitudinally in the posterior wall of the Mt and its white tone in patients with no risk factors suggest the possibility of previously unrecognized lesions and the need for close endoscopic examination, along with iodine staining and biopsy.\u0000","PeriodicalId":11354,"journal":{"name":"Diseases of the Esophagus","volume":" ","pages":""},"PeriodicalIF":2.6,"publicationDate":"2023-08-30","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"41997461","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":3,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
492. TYPES AND INCIDENCE OF POSTOPERATIVE ANEMIA AFTER ONCOLOGICAL ESOPHAGECTOMY AND GASTRECTOMY 肿瘤性食管切除术和胃切除术后贫血的类型和发生率
IF 2.6 3区 医学 Q3 GASTROENTEROLOGY & HEPATOLOGY Pub Date : 2023-08-30 DOI: 10.1093/dote/doad052.273
Aria Sallakhi, Isabella Alexandra Baumgartl, J. Andresen, Hagar Khater, Georg Gibas, Amadea Medibach, Cordula Marolt, Wolfgang Radlspöck, J. Zacherl
According to current literature, anemias that develop after oncological esophageal and gastric resections are classified as deficiency anemias. Due to the surgery-related changes in the mechanical and biochemical conditions of the upper gastrointestinal tract, there is an alteration in the processing and absorption of hematopoietic-relevant vitamins and trace elements like iron, vitamin B6, vitamin B12, folic acid, copper and essential amino acids in the postoperative phase. Between January 2015 and December 2019, 232 patients underwent a (sub)total gastrectomy or esophagectomy at our center. In this monocentric retrospective analysis of prospectively collected follow-up data, 157 patients were included after applying the exclusion criteria: Age below 18, primary bone marrow disease, hereditary forms of anemia, postoperative tumor recurrence and R1/R2 situation. 103 patients (=66%) belonged to the esophagectomy group and 54 patients (=34%) to the (sub)total gastrectomy group. Preoperatively and three, six, twelve, 18, and 24 months postoperatively the following laboratory parameters were collected and descriptively analyzed: Hemoglobin, MCV, MCH, serum iron, ferritin, transferrin, and vitamin B12. Two years after the oncological resection 28% of patients with esophagectomy, EE, and 48% of patients with (sub)total gastric resection, (S)GE, show anemia. Normocytic anemia was the dominant type. The MCV distribution of anemic patients in the EE group was as follows: 3% microcytic, 77% normocytic, and 20% macrocytic. The anemic patients in the (S)GE group show the following MCV distribution: 16% microcytic, 81% normocytic, and 3% macrocytic. The (S)GE collective has more anemic patients in percentage terms than the EE collective throughout the whole follow-up period. This difference is significant at the 12th (p = 0.032) and 18th-month (p = 0.023) postoperative follow-up. A high percentage of patients with oncological resection of the upper gastrointestinal tract have a relevant postoperative anemia. The known postoperative iron and vitamin deficiencies, that would be associated with microcytic hypochromic and macrocytic hyperchromic anemia, are not the relevant causes for this anemia as it is predominantly a normocytic form. Normocytic anemia is an indication for an anemia of chronic disease. The reason for the predominance of normocytic anemia is not specifically known.
根据目前的文献,食道和胃肿瘤切除术后发生的贫血被归类为缺乏性贫血。由于手术相关的上消化道机械生化状况的改变,术后对造血相关维生素及铁、维生素B6、维生素B12、叶酸、铜、必需氨基酸等微量元素的加工和吸收发生改变。2015年1月至2019年12月期间,232名患者在我们中心接受了(次)全胃切除术或食管切除术。在这项前瞻性随访资料的单中心回顾性分析中,采用年龄小于18岁、原发骨髓疾病、遗传性贫血、术后肿瘤复发和R1/R2情况的排除标准,纳入157例患者。食管切除术组103例(=66%),全胃切除术组54例(=34%)。术前及术后3、6、12、18、24个月采集并描述性分析以下实验室参数:血红蛋白、MCV、MCH、血清铁、铁蛋白、转铁蛋白、维生素B12。肿瘤切除两年后,28%的食管切除术(EE)患者和48%的(亚)全胃切除术(S)GE)患者出现贫血。正常细胞性贫血为优势型。EE组贫血患者的MCV分布为:小细胞型3%,正细胞型77%,大细胞型20%。(S)GE组贫血患者MCV分布如下:16%为小细胞型,81%为正细胞型,3%为大细胞型。在整个随访期间,(S)GE组比EE组有更多的贫血患者。在术后第12个月(p = 0.032)和第18个月(p = 0.023)随访时,差异有统计学意义。上消化道肿瘤切除术的患者中有很高比例的患者术后出现相关贫血。已知的术后铁和维生素缺乏,可能与小细胞性低色素血症和大细胞性高色素血症有关,但并不是这种贫血的相关原因,因为它主要是一种正红细胞贫血。正常细胞性贫血是慢性病贫血的指征。正红细胞性贫血占优势的原因尚不清楚。
{"title":"492. TYPES AND INCIDENCE OF POSTOPERATIVE ANEMIA AFTER ONCOLOGICAL ESOPHAGECTOMY AND GASTRECTOMY","authors":"Aria Sallakhi, Isabella Alexandra Baumgartl, J. Andresen, Hagar Khater, Georg Gibas, Amadea Medibach, Cordula Marolt, Wolfgang Radlspöck, J. Zacherl","doi":"10.1093/dote/doad052.273","DOIUrl":"https://doi.org/10.1093/dote/doad052.273","url":null,"abstract":"\u0000 According to current literature, anemias that develop after oncological esophageal and gastric resections are classified as deficiency anemias. Due to the surgery-related changes in the mechanical and biochemical conditions of the upper gastrointestinal tract, there is an alteration in the processing and absorption of hematopoietic-relevant vitamins and trace elements like iron, vitamin B6, vitamin B12, folic acid, copper and essential amino acids in the postoperative phase.\u0000 Between January 2015 and December 2019, 232 patients underwent a (sub)total gastrectomy or esophagectomy at our center. In this monocentric retrospective analysis of prospectively collected follow-up data, 157 patients were included after applying the exclusion criteria: Age below 18, primary bone marrow disease, hereditary forms of anemia, postoperative tumor recurrence and R1/R2 situation. 103 patients (=66%) belonged to the esophagectomy group and 54 patients (=34%) to the (sub)total gastrectomy group. Preoperatively and three, six, twelve, 18, and 24 months postoperatively the following laboratory parameters were collected and descriptively analyzed: Hemoglobin, MCV, MCH, serum iron, ferritin, transferrin, and vitamin B12.\u0000 Two years after the oncological resection 28% of patients with esophagectomy, EE, and 48% of patients with (sub)total gastric resection, (S)GE, show anemia. Normocytic anemia was the dominant type. The MCV distribution of anemic patients in the EE group was as follows: 3% microcytic, 77% normocytic, and 20% macrocytic. The anemic patients in the (S)GE group show the following MCV distribution: 16% microcytic, 81% normocytic, and 3% macrocytic. The (S)GE collective has more anemic patients in percentage terms than the EE collective throughout the whole follow-up period. This difference is significant at the 12th (p = 0.032) and 18th-month (p = 0.023) postoperative follow-up.\u0000 A high percentage of patients with oncological resection of the upper gastrointestinal tract have a relevant postoperative anemia. The known postoperative iron and vitamin deficiencies, that would be associated with microcytic hypochromic and macrocytic hyperchromic anemia, are not the relevant causes for this anemia as it is predominantly a normocytic form. Normocytic anemia is an indication for an anemia of chronic disease. The reason for the predominance of normocytic anemia is not specifically known.","PeriodicalId":11354,"journal":{"name":"Diseases of the Esophagus","volume":" ","pages":""},"PeriodicalIF":2.6,"publicationDate":"2023-08-30","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"44275905","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":3,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
397. LEFT PILLAR PINCHING TECHNIQUE FOR MINIMALLY INVASIVE REPAIR OF PARA-CONDUIT HERNIA 左柱夹闭术微创修补疝旁疝
IF 2.6 3区 医学 Q3 GASTROENTEROLOGY & HEPATOLOGY Pub Date : 2023-08-30 DOI: 10.1093/dote/doad052.198
S. Joglekar, Saee Sane, David Liu, C. Duong
Surgical repair of the para-conduit hernia provides an increasing challenge in the era of minimally invasive oesophagectomy. The key principles are preservation of the gastric conduit and its right gatro epiploic vascular arcade, and durable closure of the defect. Of various methods, posterior crural repair is difficult without mobilising and risking and kinking the conduit, while anterior repair of a big defect requires the adjunct of a mesh which carries its own risks of infection or erosion. There is no consensus on the appropriate surgical technique. We propose that the Left pillar of the hiatus be pinched to provide an effective repair. This is safe as dissection and suturing is well away from the conduit and arcade. We find the left pillar to be adequately mobile to allow repair, and the sutures sit in the tendinous portion of the left hemi diaphragm to provide durability. We provide 2 videos to describe the key steps in this technique and demonstrate that this technique is effective in both small and large defects, and acute and chronic para-conduit hernia. Link: https://1drv.ms/v/s!Anu-cyBTuGbsgbxtX8aLf2P1YEPl9g?e=fXz7Pm. Please contact me, shantjog@gmail.com if this link does not work and I will explore an alternative method to share the video. Many thanks.
在微创食管切除术时代,导管旁疝的手术修复提出了越来越大的挑战。关键原则是保留胃导管及其右门大网膜血管拱廊,并持久关闭缺损。在各种方法中,后路的脚部修复是很困难的,不需要动员、冒险和扭曲导管,而前路修复一个大的缺陷需要补片,这有感染或侵蚀的风险。对于合适的手术技术尚无共识。我们建议将裂孔的左支柱夹紧以提供有效的修复。这是安全的,因为解剖和缝合远离导管和拱廊。我们发现左支柱足够灵活,可以进行修复,缝合线位于左半隔膜的肌腱部分,提供耐用性。我们提供了两个视频来描述该技术的关键步骤,并证明该技术对大小缺陷以及急性和慢性导管旁疝都是有效的。链接:https://1drv.ms/v/s ! Anu-cyBTuGbsgbxtX8aLf2P1YEPl9g ? e = fXz7Pm。请联系我,shantjog@gmail.com如果这个链接不起作用,我会探索另一种方法来分享视频。多谢。
{"title":"397. LEFT PILLAR PINCHING TECHNIQUE FOR MINIMALLY INVASIVE REPAIR OF PARA-CONDUIT HERNIA","authors":"S. Joglekar, Saee Sane, David Liu, C. Duong","doi":"10.1093/dote/doad052.198","DOIUrl":"https://doi.org/10.1093/dote/doad052.198","url":null,"abstract":"\u0000 Surgical repair of the para-conduit hernia provides an increasing challenge in the era of minimally invasive oesophagectomy. The key principles are preservation of the gastric conduit and its right gatro epiploic vascular arcade, and durable closure of the defect.\u0000 Of various methods, posterior crural repair is difficult without mobilising and risking and kinking the conduit, while anterior repair of a big defect requires the adjunct of a mesh which carries its own risks of infection or erosion. There is no consensus on the appropriate surgical technique.\u0000 We propose that the Left pillar of the hiatus be pinched to provide an effective repair. This is safe as dissection and suturing is well away from the conduit and arcade. We find the left pillar to be adequately mobile to allow repair, and the sutures sit in the tendinous portion of the left hemi diaphragm to provide durability.\u0000 We provide 2 videos to describe the key steps in this technique and demonstrate that this technique is effective in both small and large defects, and acute and chronic para-conduit hernia.\u0000 Link: https://1drv.ms/v/s!Anu-cyBTuGbsgbxtX8aLf2P1YEPl9g?e=fXz7Pm.\u0000 Please contact me, shantjog@gmail.com if this link does not work and I will explore an alternative method to share the video.\u0000 Many thanks.","PeriodicalId":11354,"journal":{"name":"Diseases of the Esophagus","volume":" ","pages":""},"PeriodicalIF":2.6,"publicationDate":"2023-08-30","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"43036445","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":3,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
473. PARACONDUIT HIATUS HERNIA AFTER OESOPHAGECTOMY: INCIDENCE, RISK FACTORS AND MANAGEMENT 食管切除术后导管旁裂孔疝的发生率、危险因素和处理
IF 2.6 3区 医学 Q3 GASTROENTEROLOGY & HEPATOLOGY Pub Date : 2023-08-30 DOI: 10.1093/dote/doad052.255
Rakesh Ahmed, J. Elliott, C. Donohoe, N. Ravi, J. Reynolds
Hiatus hernia after oesophagectomy is an uncommon but serious complication of oesophageal cancer surgery. With improving long-term oncologic outcomes, post oesophagectomy hiatus hernia is an increasingly recognised entity in oesophageal cancer survivorship. The aim of this study was to assess the incidence of and risk factors for paraconduit hiatus hernia (PHH), and to describe management approaches in a tertiary referral centre. All patients undergoing oesophagectomy for cancer from 2008 to 2022 were included. Early PHH was defined as occurring within 3 months of index surgery, with all other PHH defined as late PHH. Surveillance computed tomography scans were undertaken among all disease-free patients to 5-years postoperatively. Kaplan Meier and Cox proportional hazards regression models were used to determine independent risk factors for PHH. 897 patients were studied. Early PHH occurred in 1.2%, and late PHH in 5.7% of patients. There was no late recurrence after early PHH. PHH was an asymptomatic radiologic finding in 45.5% of early and 84.3% of late cases. Median time to PHH was 15.7 months postoperatively. Nausea, abdominal pain and vomiting were the most common symptoms associated with PHH. Surgical intervention was required in 25.8% of cases, more commonly following early PHH (63.6%) as compared with late PHH (17.6%, P < 0.01). Operative approach (P < 0.001), extended resection of crura or diaphragm (P < 0.001) and male sex (P = 0.037) were associated with increased risk of hiatus hernia. Paraconduit hiatus hernia is an uncommon complication after oncologic oesophagectomy. Surgical intervention is often required for patients with PHH presenting in the first three months after surgery, but a majority of patients with asymptomatic late PHH may be managed expectantly.
食管癌切除术后裂孔疝是食管癌手术中一种少见但严重的并发症。随着长期肿瘤预后的改善,食管切除术后裂孔疝在食管癌生存中越来越被认可。本研究的目的是评估管道旁裂孔疝(PHH)的发生率和危险因素,并描述三级转诊中心的管理方法。所有2008年至2022年因癌症接受食管癌切除术的患者均被纳入研究。早期PHH定义为发生在指数手术3个月内,所有其他PHH定义为晚期PHH。术后5年对所有无病患者进行计算机断层扫描监测。Kaplan Meier和Cox比例风险回归模型用于确定PHH的独立危险因素。研究了897例患者。早期PHH发生率为1.2%,晚期PHH发生率为5.7%。早期PHH无晚期复发。45.5%的早期和84.3%的晚期PHH是无症状的放射学发现。术后至PHH的中位时间为15.7个月。恶心、腹痛和呕吐是PHH最常见的症状。25.8%的病例需要手术治疗,早期PHH(63.6%)较晚期PHH (17.6%, P < 0.01)更为常见。手术入路(P < 0.001)、扩大脚或膈切除术(P < 0.001)和男性(P = 0.037)与裂孔疝的风险增加相关。摘要导管旁裂孔疝是肿瘤食管切除术后少见的并发症。对于术后前三个月出现PHH的患者,通常需要手术干预,但大多数无症状晚期PHH患者可能会得到预期的治疗。
{"title":"473. PARACONDUIT HIATUS HERNIA AFTER OESOPHAGECTOMY: INCIDENCE, RISK FACTORS AND MANAGEMENT","authors":"Rakesh Ahmed, J. Elliott, C. Donohoe, N. Ravi, J. Reynolds","doi":"10.1093/dote/doad052.255","DOIUrl":"https://doi.org/10.1093/dote/doad052.255","url":null,"abstract":"\u0000 \u0000 \u0000 Hiatus hernia after oesophagectomy is an uncommon but serious complication of oesophageal cancer surgery. With improving long-term oncologic outcomes, post oesophagectomy hiatus hernia is an increasingly recognised entity in oesophageal cancer survivorship. The aim of this study was to assess the incidence of and risk factors for paraconduit hiatus hernia (PHH), and to describe management approaches in a tertiary referral centre.\u0000 \u0000 \u0000 \u0000 All patients undergoing oesophagectomy for cancer from 2008 to 2022 were included. Early PHH was defined as occurring within 3 months of index surgery, with all other PHH defined as late PHH. Surveillance computed tomography scans were undertaken among all disease-free patients to 5-years postoperatively. Kaplan Meier and Cox proportional hazards regression models were used to determine independent risk factors for PHH.\u0000 \u0000 \u0000 \u0000 897 patients were studied. Early PHH occurred in 1.2%, and late PHH in 5.7% of patients. There was no late recurrence after early PHH. PHH was an asymptomatic radiologic finding in 45.5% of early and 84.3% of late cases. Median time to PHH was 15.7 months postoperatively. Nausea, abdominal pain and vomiting were the most common symptoms associated with PHH. Surgical intervention was required in 25.8% of cases, more commonly following early PHH (63.6%) as compared with late PHH (17.6%, P < 0.01). Operative approach (P < 0.001), extended resection of crura or diaphragm (P < 0.001) and male sex (P = 0.037) were associated with increased risk of hiatus hernia.\u0000 \u0000 \u0000 \u0000 Paraconduit hiatus hernia is an uncommon complication after oncologic oesophagectomy. Surgical intervention is often required for patients with PHH presenting in the first three months after surgery, but a majority of patients with asymptomatic late PHH may be managed expectantly.\u0000","PeriodicalId":11354,"journal":{"name":"Diseases of the Esophagus","volume":" ","pages":""},"PeriodicalIF":2.6,"publicationDate":"2023-08-30","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"43159544","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":3,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
435. CIRCULAR-STAPLED ESOPHAGOGASTROSTOMY USING THE KEYHOLE PROCEDURE: TECHNICAL ASPECTS AND CLINICAL OUTCOMES 435. 环钉式食管胃造口术:技术方面和临床结果
IF 2.6 3区 医学 Q3 GASTROENTEROLOGY & HEPATOLOGY Pub Date : 2023-08-30 DOI: 10.1093/dote/doad052.227
Tsuyoshi Tanaka, Ai Goto, S. Shibasaki, Kazumitsu Suzuki, A. Serizawa, Shingo Akimoto, M. Nakauchi, K. Inaba, I. Uyama, Koichi Suda
The optimal reconstruction method after radical esophagectomy for esophageal cancer has been under debate. For avoiding an anastomotic stricture, we developed a novel method of circular-stapled esophagogastrostomy by employing the keyhole procedure, which uses a linear stapler (LS) to enlarge the anastomotic opening made with a circular stapler (CS). We report the technique and the clinical outcomes. We retrospectively reviewed 70 patients with esophageal cancer who underwent transthoracic esophagectomy and reconstruction via cervical CS-mediated anastomosis with or without the keyhole procedure between 2018 and 2020. The primary outcome was postoperative anastomotic stricture incidence within 180 days after surgery. Surgical procedures: After a 3.5 cm-wide gastric conduit was created, the blood supply was examined via indocyanine green fluorescence imaging. Usually, anastomosis was made at the site which was dominated by the last branch of the right epiploic artery owing to Kocher’s maneuver. The CS was inserted through the anterior wall of the gastric conduit, and the end-to-side anastomosis was established on the greater curvature side of the gastric conduit. Then, a 45-mm long LS was used to create a keyhole over the circular staples, and the entry hole was closed with a 60-mm long LS. Among 70 patients, 22 underwent the keyhole procedure (CS + K group) and the remaining did not (CS group). A smaller CS was used in the CS + K group (p < 0.001). The incidence of anastomotic stricture was significantly different (CS vs. CS + K, 18.8 vs. 0%, p = 0.049), especially when a 21 or 23 mm CS was used (CS vs. CS + K, 50.0 vs. 0%, p = 0.005). The univariate analysis confirmed that CS ≤ 23 without a keyhole was a significant risk factor (p = 0.001). The keyhole procedure could be a simple and useful alternative technique that reduces the risk of stricture formation in the cervical esophagogastric anastomosis, especially when using the smaller-sized CS.
癌症食管癌根治术后的最佳重建方法一直存在争议。为了避免吻合口狭窄,我们开发了一种采用锁孔程序进行环形吻合食管胃造口术的新方法,该方法使用线性缝合器(LS)扩大环形缝合器(CS)形成的吻合口。我们报告了该技术和临床结果。我们回顾性回顾了2018年至2020年间70例癌症食管癌患者,他们接受了经胸食管切除术,并通过颈CS介导吻合进行重建,无论是否采用锁孔手术。主要结果是术后180天内吻合口狭窄的发生率。外科手术:在建立3.5厘米宽的胃导管后,通过吲哚青绿荧光成像检查血液供应。通常情况下,由于Kocher的手法,吻合部位以右网膜动脉的最后一支为主。CS通过胃导管的前壁插入,并在胃导管的大曲率侧建立端侧吻合。然后,使用45mm长的LS在圆形缝钉上形成锁孔,并用60mm长的LS封闭进入孔。在70名患者中,22人接受了锁孔手术(CS + K组),其余组(CS组)没有。CS中使用了较小的CS + K组(p < 0.001)。吻合口狭窄的发生率有显著差异(CS与CS + K、 18.8对0%,p = 0.049),尤其是当使用21或23mm CS时(CS与CS + K、 50.0对0%,p = 0.005)。单变量分析证实CS ≤ 23例无锁孔是一个显著的危险因素(p = 0.001)。锁孔手术可能是一种简单而有用的替代技术,可以降低颈部食管胃吻合中狭窄形成的风险,尤其是当使用较小尺寸的CS时。
{"title":"435. CIRCULAR-STAPLED ESOPHAGOGASTROSTOMY USING THE KEYHOLE PROCEDURE: TECHNICAL ASPECTS AND CLINICAL OUTCOMES","authors":"Tsuyoshi Tanaka, Ai Goto, S. Shibasaki, Kazumitsu Suzuki, A. Serizawa, Shingo Akimoto, M. Nakauchi, K. Inaba, I. Uyama, Koichi Suda","doi":"10.1093/dote/doad052.227","DOIUrl":"https://doi.org/10.1093/dote/doad052.227","url":null,"abstract":"\u0000 \u0000 \u0000 The optimal reconstruction method after radical esophagectomy for esophageal cancer has been under debate. For avoiding an anastomotic stricture, we developed a novel method of circular-stapled esophagogastrostomy by employing the keyhole procedure, which uses a linear stapler (LS) to enlarge the anastomotic opening made with a circular stapler (CS). We report the technique and the clinical outcomes.\u0000 \u0000 \u0000 \u0000 We retrospectively reviewed 70 patients with esophageal cancer who underwent transthoracic esophagectomy and reconstruction via cervical CS-mediated anastomosis with or without the keyhole procedure between 2018 and 2020. The primary outcome was postoperative anastomotic stricture incidence within 180 days after surgery.\u0000 Surgical procedures: After a 3.5 cm-wide gastric conduit was created, the blood supply was examined via indocyanine green fluorescence imaging. Usually, anastomosis was made at the site which was dominated by the last branch of the right epiploic artery owing to Kocher’s maneuver. The CS was inserted through the anterior wall of the gastric conduit, and the end-to-side anastomosis was established on the greater curvature side of the gastric conduit. Then, a 45-mm long LS was used to create a keyhole over the circular staples, and the entry hole was closed with a 60-mm long LS.\u0000 \u0000 \u0000 \u0000 Among 70 patients, 22 underwent the keyhole procedure (CS + K group) and the remaining did not (CS group). A smaller CS was used in the CS + K group (p < 0.001). The incidence of anastomotic stricture was significantly different (CS vs. CS + K, 18.8 vs. 0%, p = 0.049), especially when a 21 or 23 mm CS was used (CS vs. CS + K, 50.0 vs. 0%, p = 0.005). The univariate analysis confirmed that CS ≤ 23 without a keyhole was a significant risk factor (p = 0.001).\u0000 \u0000 \u0000 \u0000 The keyhole procedure could be a simple and useful alternative technique that reduces the risk of stricture formation in the cervical esophagogastric anastomosis, especially when using the smaller-sized CS.\u0000","PeriodicalId":11354,"journal":{"name":"Diseases of the Esophagus","volume":" ","pages":""},"PeriodicalIF":2.6,"publicationDate":"2023-08-30","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"43558434","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":3,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
41. HIGH COMPREHENSIVE COMPLICATION INDEX AFTER MINIMALLY INVASIVE ESOPHAGECTOMY ASSOCIATED WITH POOR SHORT-TERM AND LONG-TERM OUTCOME: A PROPENSITY SCORE MATCHING ANALYSIS 41. 微创食管切除术后综合并发症指数高与短期和长期预后差相关:倾向评分匹配分析
IF 2.6 3区 医学 Q3 GASTROENTEROLOGY & HEPATOLOGY Pub Date : 2023-08-30 DOI: 10.1093/dote/doad052.016
Ding-Qiang Chen, Junlan Cai, K. Weng, Zhinuan Hong
The comprehensive complication index (CCI) is a new index to comprehensively and systematically evaluate complication severity. The objective of this study was to evaluate the predictive ability of CCI on short—and long-term overall survival(OS) in patients with esophageal squamous cell carcinoma (ESCC) undergoing minimally invasive esophagectomy (MIE) based on a propensity Score Matching (PSM) analysis. A total of 356 patients treated with radical MIE from 2013 to 2017 were included, and the primary outcome was OS, and the secondary outcomes were postoperative hospital stay and hospital costs. Firstly, the optimla cut-off value of CCI was determined by X-tile. PSM was used to balance the baseline characteristics. Second, we compared postoperative hospital stay and hospital costs between high- and low-CCI group. Third, the Kaplan–Meier survival curve was used to analyze survival difference. Fourth, univariate and multivariate Cox analysis was used to explore the independent risk factors of OS. The CCI > 24.2 was defined as high-CCI group and CCI≦24.2 was defined as low-CCI group. The high-CCI group had more hospital costs and longer hospital stay than the low-CCI group both before and after PSM (p < 0.001). The K-M analysis indicated that patients with high CCI had worse prognosis both before and after PSM (before matching: P < 0.001; after matching: P = 0.04). CCI was determined as independent prognostic factor both before and after PSM (before PSM, P = 0.002; after PSM, P = 0.025). The CCI could quantify postoperative complications after esophagectomy. High CCI is associated with longer hospital stay and hospitalization costs, and is an independent risk factor for poor OS.
综合并发症指数(CCI)是一种综合系统评价并发症严重程度的新指标。本研究的目的是基于倾向评分匹配(PSM)分析,评估CCI对食管鳞状细胞癌(ESCC)微创食管切除术(MIE)患者短期和长期总生存(OS)的预测能力。纳入2013 - 2017年接受根治性MIE治疗的356例患者,主要终点为OS,次要终点为术后住院时间和住院费用。首先,通过X-tile确定CCI的最佳临界值。PSM用于平衡基线特征。其次,我们比较了高cci组和低cci组的术后住院时间和住院费用。第三,采用Kaplan-Meier生存曲线分析生存差异。第四,采用单因素和多因素Cox分析探讨OS的独立危险因素。以CCI≦24.2为高CCI组,以CCI≦24.2为低CCI组。高cci组在PSM前后的住院费用和住院时间均高于低cci组(p < 0.001)。K-M分析显示,高CCI患者在PSM前后预后均较差(配对前:P < 0.001;配对后:P = 0.04)。在PSM前后,CCI均被确定为独立预后因素(PSM前,P = 0.002;PSM后,P = 0.025)。CCI可以量化食管切除术后的并发症。高CCI与较长的住院时间和住院费用相关,是不良OS的独立危险因素。
{"title":"41. HIGH COMPREHENSIVE COMPLICATION INDEX AFTER MINIMALLY INVASIVE ESOPHAGECTOMY ASSOCIATED WITH POOR SHORT-TERM AND LONG-TERM OUTCOME: A PROPENSITY SCORE MATCHING ANALYSIS","authors":"Ding-Qiang Chen, Junlan Cai, K. Weng, Zhinuan Hong","doi":"10.1093/dote/doad052.016","DOIUrl":"https://doi.org/10.1093/dote/doad052.016","url":null,"abstract":"\u0000 \u0000 \u0000 The comprehensive complication index (CCI) is a new index to comprehensively and systematically evaluate complication severity. The objective of this study was to evaluate the predictive ability of CCI on short—and long-term overall survival(OS) in patients with esophageal squamous cell carcinoma (ESCC) undergoing minimally invasive esophagectomy (MIE) based on a propensity Score Matching (PSM) analysis.\u0000 \u0000 \u0000 \u0000 A total of 356 patients treated with radical MIE from 2013 to 2017 were included, and the primary outcome was OS, and the secondary outcomes were postoperative hospital stay and hospital costs. Firstly, the optimla cut-off value of CCI was determined by X-tile. PSM was used to balance the baseline characteristics. Second, we compared postoperative hospital stay and hospital costs between high- and low-CCI group. Third, the Kaplan–Meier survival curve was used to analyze survival difference. Fourth, univariate and multivariate Cox analysis was used to explore the independent risk factors of OS.\u0000 \u0000 \u0000 \u0000 The CCI > 24.2 was defined as high-CCI group and CCI≦24.2 was defined as low-CCI group. The high-CCI group had more hospital costs and longer hospital stay than the low-CCI group both before and after PSM (p < 0.001). The K-M analysis indicated that patients with high CCI had worse prognosis both before and after PSM (before matching: P < 0.001; after matching: P = 0.04). CCI was determined as independent prognostic factor both before and after PSM (before PSM, P = 0.002; after PSM, P = 0.025).\u0000 \u0000 \u0000 \u0000 The CCI could quantify postoperative complications after esophagectomy. High CCI is associated with longer hospital stay and hospitalization costs, and is an independent risk factor for poor OS.\u0000 \u0000","PeriodicalId":11354,"journal":{"name":"Diseases of the Esophagus","volume":" ","pages":""},"PeriodicalIF":2.6,"publicationDate":"2023-08-30","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"45347583","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":3,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
期刊
Diseases of the Esophagus
全部 Acc. Chem. Res. ACS Applied Bio Materials ACS Appl. Electron. Mater. ACS Appl. Energy Mater. ACS Appl. Mater. Interfaces ACS Appl. Nano Mater. ACS Appl. Polym. Mater. ACS BIOMATER-SCI ENG ACS Catal. ACS Cent. Sci. ACS Chem. Biol. ACS Chemical Health & Safety ACS Chem. Neurosci. ACS Comb. Sci. ACS Earth Space Chem. ACS Energy Lett. ACS Infect. Dis. ACS Macro Lett. ACS Mater. Lett. ACS Med. Chem. Lett. ACS Nano ACS Omega ACS Photonics ACS Sens. ACS Sustainable Chem. Eng. ACS Synth. Biol. Anal. Chem. BIOCHEMISTRY-US Bioconjugate Chem. BIOMACROMOLECULES Chem. Res. Toxicol. Chem. Rev. Chem. Mater. CRYST GROWTH DES ENERG FUEL Environ. Sci. Technol. Environ. Sci. Technol. Lett. Eur. J. Inorg. Chem. IND ENG CHEM RES Inorg. Chem. J. Agric. Food. Chem. J. Chem. Eng. Data J. Chem. Educ. J. Chem. Inf. Model. J. Chem. Theory Comput. J. Med. Chem. J. Nat. Prod. J PROTEOME RES J. Am. Chem. Soc. LANGMUIR MACROMOLECULES Mol. Pharmaceutics Nano Lett. Org. Lett. ORG PROCESS RES DEV ORGANOMETALLICS J. Org. Chem. J. Phys. Chem. J. Phys. Chem. A J. Phys. Chem. B J. Phys. Chem. C J. Phys. Chem. Lett. Analyst Anal. Methods Biomater. Sci. Catal. Sci. Technol. Chem. Commun. Chem. Soc. Rev. CHEM EDUC RES PRACT CRYSTENGCOMM Dalton Trans. Energy Environ. Sci. ENVIRON SCI-NANO ENVIRON SCI-PROC IMP ENVIRON SCI-WAT RES Faraday Discuss. Food Funct. Green Chem. Inorg. Chem. Front. Integr. Biol. J. Anal. At. Spectrom. J. Mater. Chem. A J. Mater. Chem. B J. Mater. Chem. C Lab Chip Mater. Chem. Front. Mater. Horiz. MEDCHEMCOMM Metallomics Mol. Biosyst. Mol. Syst. Des. Eng. Nanoscale Nanoscale Horiz. Nat. Prod. Rep. New J. Chem. Org. Biomol. Chem. Org. Chem. Front. PHOTOCH PHOTOBIO SCI PCCP Polym. Chem.
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
0
微信
客服QQ
Book学术公众号 扫码关注我们
反馈
×
意见反馈
请填写您的意见或建议
请填写您的手机或邮箱
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
现在去查看 取消
×
提示
确定
Book学术官方微信
Book学术文献互助
Book学术文献互助群
群 号:481959085
Book学术
文献互助 智能选刊 最新文献 互助须知 联系我们:info@booksci.cn
Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。
Copyright © 2023 Book学术 All rights reserved.
ghs 京公网安备 11010802042870号 京ICP备2023020795号-1